EVRİM ŞİMŞEK, YETKİN KORKMAZ, SERDAR BOZYEL, ARDA GÜLER, DUYGU KOÇYİĞİT BURUNKAYA, MEHMET ERTÜRK, NURGÜL KESER
Archives of the Turkish Society of Cardiology - 2024;52(1):52-60
Heart Failure (HF) is an important public health problem in Turkey and in the world. Hospitalizations due to HF decompensation are associated with increased mortality. The use of digital technologies, especially wearable technologies, is increasing. As physicians, with the use of these devices, patients could be closely followed up and hospitalization, mortality are tried to be prevented by increased awareness of decomposition before clinical symptoms or at the beginning of symptoms. In this review, digital biomarkers, digital technologies, remote monitoring systems and the evidence supporting their use, artificial intelligence applications and the reasons limiting their use of digital technologies in clinical practice will be discussed.
